Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lipinski

Showing results (191-200 of 279) with videos related to

Pageof 28
Sort By:
Plos One|March 21, 2015
Definition of critical periods for Hedgehog pathway antagonist-induced holoprosencephaly, cleft lip, and cleft palateGalen W Heyne, Cal G Melberg, Padydeh Doroodchi, et al.
The Journal of Comparative Neurology|April 5, 2002
Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic miceFeng Bian, Rathna Nath, Gregg Sobocinski, et al.
The American Journal of Cardiology|September 27, 2016
Comparison in Men Versus Women of Co-morbidities, Complications, and Outcomes After Transcatheter Aortic Valve Implantation for Severe Aortic StenosisMichael A Gaglia, Michael J Lipinski, Rebecca Torguson, et al.
Environmental Health : a Global Access Science Source|June 10, 2020
Prenatal exposure to pesticides and risk for holoprosencephaly: a case-control studyYonit A Addissie, Paul Kruszka, Angela Troia, et al.
Journal of the American College of Cardiology|March 1, 2008
Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trialsAntonio Abbate, Giuseppe G L Biondi-Zoccai, Darryn L Appleton, et al.
Birth Defects Research|October 28, 2020
Identifying environmental risk factors and gene-environment interactions in holoprosencephalyYonit A Addissie, Angela Troia, Zoe C Wong, et al.
Toxicology Reports|October 4, 2023
Pharmacokinetic analysis of acute and dietary exposure to piperonyl butoxide in the mouseAlyssa E Jenkins, Cameron O Scarlett, Tyler G Beames, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 16, 2008
Dose- and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouseRobert J Lipinski, Paul R Hutson, Paul W Hannam, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2016
Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?Yohei Sotomi, Yosuke Miyazaki, Carlos Collet, et al.
The American Journal of Cardiology|September 9, 2008
Safety of drug-eluting stents in patients with left ventricular dysfunction undergoing percutaneous coronary interventionAnnunziata Nusca, Michael J Lipinski, Amit Varma, et al.
Pageof 28

Showing results (191-200 of 279) with videos related to

Sort By:
Pageof 28
Plos One|March 21, 2015
Definition of critical periods for Hedgehog pathway antagonist-induced holoprosencephaly, cleft lip, and cleft palateGalen W Heyne, Cal G Melberg, Padydeh Doroodchi, et al.
The Journal of Comparative Neurology|April 5, 2002
Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic miceFeng Bian, Rathna Nath, Gregg Sobocinski, et al.
The American Journal of Cardiology|September 27, 2016
Comparison in Men Versus Women of Co-morbidities, Complications, and Outcomes After Transcatheter Aortic Valve Implantation for Severe Aortic StenosisMichael A Gaglia, Michael J Lipinski, Rebecca Torguson, et al.
Environmental Health : a Global Access Science Source|June 10, 2020
Prenatal exposure to pesticides and risk for holoprosencephaly: a case-control studyYonit A Addissie, Paul Kruszka, Angela Troia, et al.
Journal of the American College of Cardiology|March 1, 2008
Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trialsAntonio Abbate, Giuseppe G L Biondi-Zoccai, Darryn L Appleton, et al.
Birth Defects Research|October 28, 2020
Identifying environmental risk factors and gene-environment interactions in holoprosencephalyYonit A Addissie, Angela Troia, Zoe C Wong, et al.
Toxicology Reports|October 4, 2023
Pharmacokinetic analysis of acute and dietary exposure to piperonyl butoxide in the mouseAlyssa E Jenkins, Cameron O Scarlett, Tyler G Beames, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 16, 2008
Dose- and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouseRobert J Lipinski, Paul R Hutson, Paul W Hannam, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2016
Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?Yohei Sotomi, Yosuke Miyazaki, Carlos Collet, et al.
The American Journal of Cardiology|September 9, 2008
Safety of drug-eluting stents in patients with left ventricular dysfunction undergoing percutaneous coronary interventionAnnunziata Nusca, Michael J Lipinski, Amit Varma, et al.
Pageof 28